Subscribe to RSS

DOI: 10.1055/s-0044-1788704
The Unusual Presentation of Bilateral Proptosis Presents a Dilemma in the Case of Juvenile Myelomonocytic Leukemia
Authors
Funding None.
Abstract
Juvenile myelomonocytic leukemia (JMML) is a myelodysplastic/myeloproliferative neoplasm. It is a rare pediatric neoplasm occurring in early childhood. Herein, we present a case of JMML in a 4-year-old girl admitted for primary complaints of protrusion of eyes and fever for the past 15 days not responding to any medications. With findings of splenomegaly and peripheral blood smear showing severe leukocytosis and increased monocytoid and blast cells, a myelomonocytic series neoplasm was suspected. Abelson (Abl) tyrosine kinase gene break point cluster (Bcr) gene (BCR-ABL1) was found to be negative on fluorescence in situ hybridization (FISH). Taking into consider all these findings, the patient was diagnosed with JMML. Since hematopoietic stem cell transplantation (HSCT) is not offered at our hospital, the patient was referred to another medical facility for the required procedure. This case highlights that bilateral proptosis could be a primary finding in early cases of JMML and should not be missed.
Patient Consent
Declaration of the patient consent form
Written, Informed Patient Consent: Obtained
All authors have read and approved the final manuscript.
Publication History
Article published online:
31 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res 2009; 33 (03) 355-362
- 2 Emanuel PD. Juvenile myelomonocytic leukemia. Curr Hematol Rep 2004; 3 (03) 203-209
- 3 Niemeyer CM, Arico M, Basso G. et al; European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood 1997; 89 (10) 3534-3543
- 4 Emanuel PD. Myelodysplasia and myeloproliferative disorders in childhood: an update. Br J Haematol 1999; 105 (04) 852-863
- 5 Sasaki H, Manabe A, Kojima S. et al; MDS Committee of the Japanese Society of Pediatric Hematology, Japan. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 2001; 15 (11) 1713-1720
- 6 Tartaglia M, Niemeyer CM, Fragale A. et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34 (02) 148-150
- 7 Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. Mutations of the N-RAS gene in juvenile chronic myelogenous leukemia. Blood 1994; 83 (08) 2248-2254
- 8 Side LE, Emanuel PD, Taylor B. et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998; 92 (01) 267-272
- 9 Flotho C, Valcamonica S, Mach-Pascual S. et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999; 13 (01) 32-37
- 10 Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 1994; 70 (05) 969-972
- 11 Bader-Meunier B, Tchernia G, Miélot F. et al. Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997; 130 (06) 885-889
- 12 Urs L, Stevens L, Kahwash SB. Leukemia presenting as solid tumors: report of four pediatric cases and review of the literature. Pediatr Dev Pathol 2008; 11 (05) 370-376
- 13 Niemeyer CM, Kang MW, Shin DH. et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 2010; 42 (09) 794-800
- 14 Nambu M, Shimizu K, Ito S, Ohta S. A case of juvenile myelomonocytic leukemia with ocular infiltration. Ann Hematol 1999; 78 (12) 568-570
- 15 Chang GC, Moshfeghi DM, Alcorn DM. Choroidal infiltration in juvenile myelomonocytic leukaemia. Br J Ophthalmol 2006; 90 (08) 1067-1067
- 16 Davies JNP, Owor R. Chloromatous tumours in African children in Uganda. BMJ 1965; 2 (5458): 405-407
- 17 Stockl FA, Dolmetsch AM, Saornil MA, Font RL, Burnier Jr MN. Orbital granulocytic sarcoma. Br J Ophthalmol 1997; 81 (12) 1084-1088
- 18 Hmidi K, Zaouali S, Messaoud R. et al. Bilateral orbital myeloid sarcoma as initial manifestation of acute myeloid leukemia. Int Ophthalmol 2007; 27 (06) 373-377
- 19 Janik-Moszant A, Barć-Czarnecka M, van der Burg M. et al. Concomitant EBV-related B-cell proliferation and juvenile myelomonocytic leukemia in a 2-year-old child. Leuk Res 2008; 32 (01) 181-184
- 20 Lorenzana A, Lyons H, Sawaf H, Higgins M, Carrigan D, Emanuel PD. Human herpesvirus 6 infection mimicking juvenile myelomonocytic leukemia in an infant. J Pediatr Hematol Oncol 2002; 24 (02) 136-141
- 21 Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991; 77 (05) 925-929
- 22 Arber DA, Orazi A, Hasserjian R. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127 (20) 2391-2405
- 23 Hasegawa D, Bugarin C, Giordan M. et al. Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia. Blood Cancer J 2013; 3 (11) e160-e160
- 24 Locatelli F, Nöllke P, Zecca M. et al; European Working Group on Childhood MDS, European Blood and Marrow Transplantation Group. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005; 105 (01) 410-419
- 25 Niemeyer CM, Kratz C. Juvenile myelomonocytic leukemia. Curr Oncol Rep 2003; 5 (06) 510-515
- 26 Bergstraesser E, Hasle H, Rogge T. et al. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer 2007; 49 (05) 629-633
- 27 Fabri O, Horakova J, Bodova I. et al. Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approaches. Neoplasma 2019; 66 (05) 818-824
- 28 Hashmi SK, Punia JN, Marcogliese AN. et al. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer 2019; 66 (10) e27905
